KYSENSE® is a CE-marked class III medical device, a cross-linked hyaluronic acid dermal filler for the facial anatomy, manufactured by Swiss based KYLANE LABORATOIRES, an innovative biomedical company dedicated to breakthrough research and clinical science, with a team of experts bringing 50years of experience in HA science and technologies, contributing to more than 20 patents globally.
Claire Williams, chief executive of global distributor Circa Skin, says: “Kysense represents an exciting innovation and step forward in what clinical practitioners can offer their patients and we are delighted with the positive feedback we have had from our existing customers.
In addition, we are revolutionising the business aspect for our customers, with the recent launch of a subscription service to support our clinicians in maximising their clinical and commercial returns.”
KYSENSE® has been developed by scientists in collaboration with doctors with decades of experience in the HA-dermal filler market and who contribute to peer reviewed publications in HA technology and facial aesthetics.
The KYSENSE® manufacturing process (HA Protect) preserves the long HA chains leading to a smooth, supple gel matrix with advantageous rheological properties, without the need of the addition of lidocaine.
KYSENSE® offers versatility for the injector, with four product choices to treat all areas of the face, offering an increased injection precision with a higher projection capability whilst respecting the four key rheological parameters. For the patient, KYSENSE® offers a natural look and feel with high patient satisfaction. Less is more with KYSENSE®. The four lines in the product range are outlined below.
For more information visit circaskin.co.uk